(Q48408044)

English

Stabilization of lung function and clinical symptoms in a patient with cystic fibrosis (CF) after institution of infliximab: a monoclonal antibody that binds tumor necrosis factor alpha.

scientific article published on 27 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

Stabilization of lung function and clinical symptoms in a patient with cystic fibrosis (CF) after institution of infliximab: a monoclonal antibody that binds tumor necrosis factor alpha. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

cystic fibrosis

0 references

author name string

Brian Casserly

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

Walter Donat

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

publication date

27 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

187

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

149-152

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

https://scigraph.springernature.com/pub.10.1007/s00408-009-9138-6

0 references

Inflammatory cytokines in cystic fibrosis lungs

1 reference

https://api.crossref.org/works/10.1007%2FS00408-009-9138-6

21 January 2018

Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation and anti-inflammatory therapies for cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept for refractory asthma therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of free radicals in the pathogenesis of cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of high-dose ibuprofen in patients with cystic fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNF therapy: where have we got to in 2005?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cystic fibrosis mouse models

1 reference

https://pubmed.ncbi.nlm.nih.gov/19247707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00408-009-9138-6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19247707

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48408044&oldid=1402596792"